HAS heads into tomorrow's Q2 print riding a sharp 13% one-week rally — and options traders are treating that move with visible caution.
The clearest tension is in options positioning. The put/call ratio jumped to 0.84, nearly two standard deviations above its 20-day average of 0.55 — its most defensive reading in roughly a month. That shift happened precisely as the stock surged, suggesting investors are buying downside protection into the report rather than chasing further upside. The PCR peaked above 1.05 earlier in June at lower prices; now, at $88.78, the hedging is nearly as intense.
Short interest tells a more relaxed story. About 6.1% of the free float is held short — meaningful but not extreme — and borrow conditions are essentially unconstrained. Availability runs at nearly 2,800% of short interest, meaning the lending pool is enormous relative to what shorts have actually borrowed. Cost to borrow has fallen roughly 26% over the past week to 0.37%, a low figure consistent with no squeeze pressure whatsoever. Short interest itself ticked up about 7% on the week to 8.5 million shares, but remains below mid-June levels. The ORTEX short score of 42.8 is mid-range and has barely moved in ten days — no unusual bearish conviction building in the lending market.
The analyst community has been trimming targets ahead of the print but holding its constructive view. Jefferies and B of A Securities both lowered targets last week — to $110 and $105 respectively — while keeping Buy ratings. Citigroup cut to $101 and BNP Paribas to $114, both maintaining positive calls. Wells Fargo, the outlier, sits at Equal-Weight with a $85 target sitting essentially at the current price. The consensus mean of $108 implies roughly 22% upside from current levels, but the direction of travel has been one-way: every firm that moved in the past two weeks moved lower. The bull case centres on global toy market momentum — retail toy sales up 7% year-over-year — plus digital licensing growth through Dungeons & Dragons Beyond. Bears counter with regional fragmentation: North America, Asia Pacific, and Latin America all posted year-over-year revenue declines, and tariff-related inventory risk adds an operational wildcard for the back half.
The earnings print will therefore test whether the company's consumer products recovery is broad enough to justify the stock's 13% surge, or whether regional weakness and guidance conservatism give the hedging in the options market a reason to pay off.
See the live data behind this article on ORTEX.
Open HAS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
